Funds will allow for a rapid transition through pre-commercialization to market launch.
Amadeus Capital Partners Ltd
Amadeus Capital Partners is a global technology investor. Since 1997, the firm has raised over $1bn for investment and used it to back more than 130 companies. With vast experience and a great network, Amadeus’ team of investors and entrepreneurs share a passion for the transformative power of technology. We invest in consumer services, financial technology, artificial intelligence, cyber security, medical technology, digital healthcare and digital media.
Telephone: +44 (0)330 024 0777
Address :
Suite 1 2/F 2 Quayside Cambridge
Post Code: CB5 8AB
Country: United Kingdom
Website: https://www.amadeuscapital.com
Membership Type: Founder Member
With vast experience and a great network, Amadeus’ team of investors and entrepreneurs share a passion for the transformative power of technology. We invest in consumer services, financial technology, artificial intelligence, cyber security, medical technology, digital healthcare and digital media.
Early stage investments we’ve made include rare disease treatment discovery platform Healx, massively parallel simulation platform Improbable; Graphcore, innovators in intelligent microprocessors, and speech recognition company VocalIQ (acquired by Apple).
To learn more visit https://amadeuscapital.comand follow us on Twitter @AmadeusCapital.
There are no Products & Services to display
19-01-2022
Medtech startup Charco's seed round, led by Amadeus Capital Partners and Parkwalk Advisors, will support the launch of CUE1, a novel therapy with a waiting list of more than 5000 people. It is the largest European seed financing and sixth largest globally in 2021 for healthtech devices. Charco collaborates with the European Parkinson’s Disease Association to help provide the latest solutions...
19-11-2021
Amadeus Capital Partners has announced that it has expanded its deep tech investment team with the appointment of Dr Manjari Chandran-Ramesh as a Partner in its Early Stage Team. Manjari will focus on investing in start-ups and spinouts centring on machine learning and quantum technologies, in the Oxford innovation cluster and other university centres throughout the UK.
05-11-2021
Amadeus CEO Anne Glover has won the prestigious award Hall of Fame Award at GP Bullhound’s Investor Allstars event.
20-10-2021
Oxford Nanopore’s successful IPO is inspiring news for biotech entrepreneurs and a testament to the extraordinary vision of its founder and CEO Gordon Sanghera.
04-10-2021
Altana AI has secured $15 million in Series A funding, led by GV (formerly Google Ventures). Floating Point, Ridgeline Partners. Existing investors Amadeus Capital Partners and Schematic Ventures joined the round, which closed in May 2021.
22-09-2021
PolyAI raises $14m from Khosla Ventures to accelerate US expansion for ‘superhuman’ voice assistants
Enterprise voice bot market heats up as companies use AI to route calls, answer questions, book reservations and take orders.
13-09-2021
Amadeus Capital Partners, the global technology investor, reinforces commitment to Latin America by hiring a new partner in São Paulo, Beatriz Amary.
24-08-2021
Transformational Augmented Reality (AR) platform sets a new standard in construction. Uses holograms to deliver megaprojects across Europe.
17-06-2021
Cryptosense, a cryptography lifecycle management platform, has announced a $4.8 million funding round led by Amadeus Capital Partners with participation from BGV and Elaia Partners.
14-05-2021
Sprout.ai, the company that uses AI to enable insurance claims to be settled within just 24 hours, announced that it has raised £8m ($11m) in Series A funding.
07-05-2021
Global technology investor Amadeus Capital Partners has announced the closing at £110 million of its latest early stage, deep tech investment platform, the Amadeus V Technology Fund, which includes a cornerstone commitment by British Patient Capital, the UK’s largest investor in venture and venture growth opportunities.
06-05-2021
Doctify, a healthcare review platform, has announced an additional $7.5M in its latest funding round, taking the overall investment to $20M.
14-04-2021
CDC Group (CDC), the UK’s publicly owned impact investor, has appointed two of the best-known names in the venture capital industry as investment committee members, as it prepares to expand its interests in the sector.
04-02-2021
University of Cambridge spin-out Xampla has announced it has closed a £6.2m seed finance round, led by the backers of Zoom, to accelerate the roll-out of its next-generation plastic replacement. The investment follows a £2m round announced in April.
11-01-2021
Graphcore – maker of the Intelligence Processing Unit which is a new type of microprocessor specifically designed to support artificial intelligence workloads – announced that it has raised $222 million in a Series E funding round that values the company at $2.77 billion post-money.
30-12-2020
V7 Labs, the computer vision platform trusted by hundreds of customers including Tractable, GE Healthcare and Merck, has announced the closing of a $3M Seed round led by Amadeus Capital Partners, joined by Partech, Air Street Capital, and Miele Venture.
21-12-2020
New York, NY – Altana AI, a start-up working with governments, global enterprises, and supply chain solutions providers to de-risk global supply chains, announced a seed investment of $7 million. The funding round was led by Amadeus Capital Partners, a London-based venture capital firm with a long track record of backing artificial intelligence, risk management, and national security...
25-11-2020
Pimloc, the visual privacy and security company, has closed £1.4m in new financing in a seed funding round led by Amadeus Capital Partners with participation from Speedinvest and existing shareholders.
19-10-2020
Veritas Intercontinental, a leader in the application of preventive genomic medicine, has completed a new financing of €5 million that strengthens its international expansion and the development of new operational and technological capabilities.
17-10-2020
Pages
There are no events to display
There are no jobs to display
No Blog articles found
